Evaluation of significance of the 7th edition of the International Union against Cancer/American Joint Committee on Cancer staging system for nasopharyngeal carcinoma with intensity-modulated radiotherapy
Jiang feng, Hu Fujun, Hu Qiaoying, Feng Xinglai, Li Bing, Bao Wuan, Qin Weifeng, Jing Qifeng, Chen Yuanyuan, Tao Qiu, Piao Yongfeng, Hua Yonghong,Jin Ting,Tao Changjuan, Chen Xiaozhong
Department of Radiation Oncology, Zhejiang Cancer Hosptial, Hangzhou 310022, China
Abstract：Objective To evaluate the rationality and applicability of the 7th edition of the International Union against Cancer/American Joint Committee on Cancer (UICC/AJCC) staging system for nasopharyngeal carcinoma (NPC) in patients staged by magnetic resonance imaging (MRI) and treated with intensity-modulated radiotherapy (IMRT). Methods The clinical outcomes of 720 patients diagnosed with stage M0 NPC who were staged by MRI and treated with IMRT in our hospital from 2007 to 2011 were retrospectively analyzed, and the reliability of T and N staging in prediction of clinical outcomes in patients was evaluated. The survival rates were calculated using the Kaplan-Meier method, and pairwise comparisons were made using the log-rank test. Multivariate prognostic analyses were performed using the Cox regression model. Results The 7th edition of UICC/AJCC T stag was an independent prognostic factor for overall survival (OS), cancer-specific survival (CSS), disease-free survival (DFS), and distant metastasis-free survival (DMFS) rates (P=0.013, 0.025, 0.001, and 0.002). However, differences between stages T1, T2, and T3 were not significant (P=0.054-0.626). Patients with stage T3 NPC had a similar level of risk for local recurrence and distant metastasis compared with patients with stage T2 NPC (P=0.796). The N stage was an independent prognostic factor for DFS and DMFS rates (P=0.005 and 0.000). There were no significant differences in DFS and DMFS rates between stages N0 and N1(P=0.549 and 0.707). In stages N0-N1, retropharyngeal lymph node metastasis only was not an independent prognostic factor for OS, DFS, and DMFS (P=0.360, 0.083, and 0.062). Conclusions The 7th edition of UICC/AJCC staging system for NPC is still valuable for prediction of the prognosis of patients staged by MRI and treated by IMRT. Optimization of the staging system can improve the prognostic accuracy.
Jiang feng,Hu Fujun,Hu Qiaoying et al. Evaluation of significance of the 7th edition of the International Union against Cancer/American Joint Committee on Cancer staging system for nasopharyngeal carcinoma with intensity-modulated radiotherapy[J]. Chinese Journal of Radiation Oncology, 2015, 24(3): 281-284.
[1] 胡福军,陈晓钟,姜锋,等.局部晚期鼻咽癌新辅助化疗加同期调强放疗及辅助化疗疗效分析[J].浙江医学,2010,32(6):836-839. [2] Ng SH, Chang JT, Chan SC, et al. Nodal metastases of nasopharyngeal carcinoma:patterns of disease on MRI and FDG-PET[J]. Eur J Nucl Med Mol Imaging,2004,31(8):1073-1080. [3] Som PM. Detection of metastasis in cervical lymph nodes:CT and MR criteria and differential diagnosis[J]. Am J Roentgenol,1992,158(5):961-969. [4] Van den Brekel MW, Stel HV, Castelijns JA, et al. Cervical lymph node metastasis:assessment of radiologic criteria[J].Radiology,1990,177(2):379-384. [5] Groome PA, Schulze K, Boysen M,et al. A comparison of published head and neck stage groupings in carcinomas of the oral cavity[J].Head Neck,2001,23(8):613-624. [6] Tham IW,Hee SW,Yeo RM,et al. Treatment of nasopharyngeal carcinoma using intensity-modulated radiotherapy-The National Cancer Centre Singapore experience[J].Int J Radiat Oncol Biol Phys,2009,75(5):1481-1486.DOI:10.1016/j.ijrobp.2009.01.018. [7] Mao YP,Xie FY,Liu LZ,et al. Re-evaluation of 6th edition of AJCC staging system for nasopharyngeal carcinoma and proposed improvement based on magnetic resonance imaging[J].Int J Radiat Oncol Biol Phys,2009,73(5):1326-1334.DOI:10.1016/j.ijrobp.2008.07.062. [8] Ma J,Liu L,Tang L,et al. Retropharyngeal lymph node metastasis in nasopharyngeal carcinoma:prognostic value and staging categories[J]. Clin Cancer Res,2007,13(5):1445-1452. [9] Tang LL, Guo R, Zhou G, et al. Prognostic value and staging classification of retropharyngeal lymph node metastasis in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy[J/OL]. PLoS One,2014,9(10):e108375[2014-11-20].http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4193733/.DOI:10.1371/journal.pone.0108375. [10] Lee AW, Au JS, Teo PM, et al. Staging of nasopharyngeal carcinoma:suggestions for improving the current UICC/AJCC staging system[J]. Clin Oncol,2004,16(4):269-276. [11] Chua DT, Nicholls JM, Sham JS,et al. Prognostic value of epidermal growth factor receptor expression in patietns with advanced nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy[J]. Int J Radiat Oncol Phys,2004,59(1):11-20.
2015, Vol. 24 
